Recent Finacing
Recent Raise
Araris Biotech is a Swiss spin‑off developing an ADC linker platform that attaches any payload to off‑the‑shelf antibodies in one step, producing stable, monomeric ADCs with defined drug‑to‑antibody ratios.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
